AI-generated Recursion Pharmaceuticals (RXRX) stock analysis report, as of Nov 3, 2026. See RXRX business overview, financial statement overview, technical analysis and price target.

Git security updates fix six flaws, including one that lets malicious repositories execute attacker code during recursive cloning.

Salt Lake City, UT, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering ...

Anthropic has warned that it may be approaching a stage in artificial intelligence development where AI systems significantly ...

A recursive call is 'a function calling itself during its execution.' The three axes to memorize are 'stopping condition, ...

In addition to that, given the crosstalk that is known between MAPK pathway and beta-catenin, MEK1/2 can also dampen some of the growth signals driven by APC loss. It is that platform insight that led ...

Good morning, everyone, and thank you for joining Recursion's Third Quarter Earnings Call. We're hosting earnings live from ...

Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...

Recursion’s Q3 2026 earnings call highlighted REC-4881 FAP data, REC-1245 tumor responses, $749 million in pro forma cash and ...

Anthropic is reportedly close to developing a model capable of recursive self-improvement (RSI). This would significantly accelerate AI capabilities. Anthropic appears to consider both potential ...

Tencent's Hunyuan Research Agent version 2.0 made its debut Monday, claiming to have crossed a threshold that has defined the ambition of AI-for-science research for a decade: instead of solving ...